Sublingual and oral immunotherapy.

Immunol Allergy Clin North Am

Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Padiglione Maragliano, L.go R. Benzi 10, Genoa 16132, Italy.

Published: November 2004

Sublingual immunotherapy (SLIT) is a viable alternative to the subcutaneous route for the treatment of respiratory allergy, whereas the pure oral route has been abandoned because of its lack of efficacy. The main distinctive feature of SLIT is its optimal safety profile, which has been demonstrated in adults and children. The indications for SLIT are similar to those for the subcutaneous route. A long-lasting effect has been demonstrated for the sublingual route, but data are needed to determine the optimal dose and the preventive effect in asthma.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iac.2004.07.001DOI Listing

Publication Analysis

Top Keywords

subcutaneous route
8
sublingual oral
4
oral immunotherapy
4
immunotherapy sublingual
4
sublingual immunotherapy
4
immunotherapy slit
4
slit viable
4
viable alternative
4
alternative subcutaneous
4
route
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!